{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T22:31:01Z","timestamp":1780698661522,"version":"3.54.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:00:00Z","timestamp":1604534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:00:00Z","timestamp":1604534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Projekt DEAL"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Podocyte injury has recently been described as unifying feature in idiopathic nephrotic syndromes (INS). Puumala hantavirus (PUUV) infection represents a unique RNA virus-induced renal disease with significant proteinuria. The underlying pathomechanism is unclear. We hypothesized that PUUV infection results in podocyte injury, similar to findings in INS. We therefore analyzed standard markers of glomerular proteinuria (e.g. immunoglobulin G [IgG]), urinary nephrin excretion (podocyte injury) and serum levels of the soluble urokinase plasminogen activator receptor (suPAR), a proposed pathomechanically involved molecule in INS, in PUUV-infected patients. Hantavirus patients showed significantly increased urinary nephrin, IgG and serum suPAR concentrations compared to healthy controls. Nephrin and IgG levels were significantly higher in patients with severe proteinuria than with mild proteinuria, and nephrin correlated strongly with biomarkers of glomerular proteinuria over time. Congruently, electron microcopy analyses showed a focal podocyte foot process effacement. suPAR correlated significantly with urinary nephrin, IgG and albumin levels, suggesting suPAR as a pathophysiological mediator in podocyte dysfunction. In contrast to INS, proteinuria recovered autonomously in hantavirus patients. This study reveals podocyte injury as main cause of proteinuria in hantavirus patients. A better understanding of the regenerative nature of hantavirus-induced glomerulopathy may generate new therapeutic approaches for INS.<\/jats:p>","DOI":"10.1038\/s41598-020-76050-0","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T11:03:19Z","timestamp":1604574199000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Glomerular filtration barrier dysfunction in a self-limiting, RNA virus-induced glomerulopathy resembles findings in idiopathic nephrotic syndromes"],"prefix":"10.1038","volume":"10","author":[{"given":"Christian","family":"Nusshag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisa","family":"St\u00fctz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"H\u00e4gele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudius","family":"Speer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"K\u00e4lble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Eckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus A.","family":"Weigand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Morath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Reiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Zeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Krautkr\u00e4mer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,5]]},"reference":[{"key":"76050_CR1","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1007\/s00134-020-06153-9","volume":"46","author":"P Gabarre","year":"2020","unstructured":"Gabarre, P. et al. Acute kidney injury in critically ill patients with COVID-19. Intens. Care Med. 46, 1339\u20131348 (2020).","journal-title":"Intens. Care Med."},{"key":"76050_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.kint.2020.05.006","volume":"98","author":"JS Hirsch","year":"2020","unstructured":"Hirsch, J. S. et al. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int. 98, 209\u2013218 (2020).","journal-title":"Kidney Int."},{"key":"76050_CR3","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1056\/NEJMc2011400","volume":"383","author":"VG Puelles","year":"2020","unstructured":"Puelles, V. G. et al. Multiorgan and renal tropism of SARS-CoV-2. N. Engl. J. Med. 383, 590\u2013592 (2020).","journal-title":"N. Engl. J. Med."},{"key":"76050_CR4","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.kint.2020.04.003","volume":"98","author":"H Su","year":"2020","unstructured":"Su, H. et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int. 98, 219\u2013227 (2020).","journal-title":"Kidney Int."},{"key":"76050_CR5","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.kint.2020.03.005","volume":"97","author":"Y Cheng","year":"2020","unstructured":"Cheng, Y. et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 97, 829\u2013838 (2020).","journal-title":"Kidney Int."},{"key":"76050_CR6","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/nrmicro3066","volume":"11","author":"A Vaheri","year":"2013","unstructured":"Vaheri, A. et al. Uncovering the mysteries of hantavirus infections. Nat. Rev. Microbiol. 11, 539\u2013550 (2013).","journal-title":"Nat. Rev. Microbiol."},{"key":"76050_CR7","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.virusres.2018.11.015","volume":"260","author":"S H\u00e4gele","year":"2019","unstructured":"H\u00e4gele, S. et al. Virus- and cell type-specific effects in orthohantavirus infection. Virus Res. 260, 102\u2013113 (2019).","journal-title":"Virus Res."},{"key":"76050_CR8","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3201\/eid2101.140861","volume":"21","author":"J Latus","year":"2015","unstructured":"Latus, J. et al. Clinical course and long-term outcome of hantavirus-associated nephropathia epidemica, Germany.  Emerg. Infect. Dis. 21, 76\u201383 (2015).","journal-title":"Emerg. Infect. Dis."},{"key":"76050_CR9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jcv.2017.07.007","volume":"94","author":"C Nusshag","year":"2017","unstructured":"Nusshag, C. et al. Deregulation of levels of angiopoietin-1 and angiopoietin-2 is associated with severe courses of hantavirus infection. J. Clin. Virol. 94, 33\u201336 (2017).","journal-title":"J. Clin. Virol."},{"key":"76050_CR10","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1186\/1471-2334-13-501","volume":"13","author":"J Rasmuson","year":"2013","unstructured":"Rasmuson, J. et al. Cardiopulmonary involvement in puumala hantavirus infection. BMC Infect. Dis. 13, 501 (2013).","journal-title":"BMC Infect. Dis."},{"key":"76050_CR11","first-page":"121","volume":"41","author":"J Mustonen","year":"1994","unstructured":"Mustonen, J. et al. Renal biopsy findings and clinicopathologic correlations in nephropathia epidemica. Clin. Nephrol. 41, 121\u2013126 (1994).","journal-title":"Clin. Nephrol."},{"key":"76050_CR12","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1053\/j.ajkd.2009.04.025","volume":"54","author":"AG Lordemann","year":"2009","unstructured":"Lordemann, A. G. et al. Young man with kidney failure and hemorrhagic interstitial nephritis. Am. J. Kidney Dis. 54, 1162\u20131166 (2009).","journal-title":"Am. J. Kidney Dis."},{"key":"76050_CR13","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1159\/000459634","volume":"136","author":"PS Mantula","year":"2017","unstructured":"Mantula, P. S. et al. Glomerular proteinuria predicts the severity of acute kidney injury in puumala hantavirus-induced tubulointerstitial nephritis. Nephron 136, 193\u2013201 (2017).","journal-title":"Nephron"},{"key":"76050_CR14","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1093\/ndt\/17.2.246","volume":"17","author":"I Ala-Houhala","year":"2002","unstructured":"Ala-Houhala, I. et al. Increased glomerular permeability in patients with nephropathia epidemica caused by Puumala hantavirus. Nephrol. Dial. Transplant 17, 246\u2013252 (2002).","journal-title":"Nephrol. Dial. Transplant"},{"key":"76050_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000486322","volume":"8","author":"M Meier","year":"2018","unstructured":"Meier, M. et al. Proteinuria and the clinical course of dobrava-belgrade hantavirus infection. Nephron Extra. 8, 1\u201310 (2018).","journal-title":"Nephron Extra."},{"key":"76050_CR16","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/s41581-019-0217-5","volume":"15","author":"MA Saleem","year":"2019","unstructured":"Saleem, M. A. Molecular stratification of idiopathic nephrotic syndrome. Nat. Rev. Nephrol. 15, 750\u2013765 (2019).","journal-title":"Nat. Rev. Nephrol."},{"key":"76050_CR17","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/nrneph.2016.147","volume":"12","author":"RJ Maas","year":"2016","unstructured":"Maas, R. J., Deegens, J. K., Smeets, B., Moeller, M. J. & Wetzels, J. F. Minimal change disease and idiopathic FSGS: manifestations of the same disease. Nat. Rev. Nephrol. 12, 768\u2013776 (2016).","journal-title":"Nat. Rev. Nephrol."},{"key":"76050_CR18","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/nm.2411","volume":"17","author":"C Wei","year":"2011","unstructured":"Wei, C. et al. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat. Med. 17, 952\u2013960 (2011).","journal-title":"Nat. Med."},{"key":"76050_CR19","doi-asserted-by":"publisher","first-page":"e71335","DOI":"10.1371\/journal.pone.0071335","volume":"8","author":"TK Outinen","year":"2013","unstructured":"Outinen, T. K. et al. Plasma levels of soluble urokinase-type plasminogen activator receptor associate with the clinical severity of acute Puumala hantavirus infection. PLoS ONE 8, e71335 (2013).","journal-title":"PLoS ONE"},{"key":"76050_CR20","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s13054-020-02897-4","volume":"24","author":"N Rovina","year":"2020","unstructured":"Rovina, N. et al. Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia. Crit. Care 24, 187 (2020).","journal-title":"Crit. Care"},{"key":"76050_CR21","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/ki.2014.197","volume":"87","author":"B Meijers","year":"2015","unstructured":"Meijers, B. et al. Soluble urokinase receptor is a biomarker of cardiovascular disease in chronic kidney disease. Kidney Int. 87, 210\u2013216 (2015).","journal-title":"Kidney Int."},{"key":"76050_CR22","doi-asserted-by":"publisher","first-page":"4091","DOI":"10.1182\/blood.V96.13.4091","volume":"96","author":"N Sidenius","year":"2000","unstructured":"Sidenius, N. et al. Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection. Blood 96, 4091\u20134095 (2000).","journal-title":"Blood"},{"key":"76050_CR23","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1046\/j.1523-1755.1999.00769.x","volume":"56","author":"A Laurinavicius","year":"1999","unstructured":"Laurinavicius, A., Hurwitz, S. & Rennke, H. G. Collapsing glomerulopathy in HIV and non-HIV patients: a clinicopathological and follow-up study. Kidney Int. 56, 2203\u20132213 (1999).","journal-title":"Kidney Int."},{"key":"76050_CR24","doi-asserted-by":"publisher","first-page":"3232848","DOI":"10.1155\/2017\/3232848","volume":"2017","author":"RR Dande","year":"2017","unstructured":"Dande, R. R., Peev, V., Altintas, M. M. & Reiser, J. Soluble urokinase receptor and the kidney response in diabetes mellitus. J. Diabetes Res. 2017, 3232848\u20133232849 (2017).","journal-title":"J. Diabetes Res."},{"key":"76050_CR25","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1093\/infdis\/jix266","volume":"216","author":"DM Kirkegaard-Klitbo","year":"2017","unstructured":"Kirkegaard-Klitbo, D. M. et al. Soluble urokinase plasminogen activator receptor is a predictor of incident non-AIDS comorbidity and all-cause mortality in human immunodeficiency virus type 1 infection. J. Infect Dis. 216, 819\u2013823 (2017).","journal-title":"J. Infect Dis."},{"key":"76050_CR26","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nm1696","volume":"14","author":"C Wei","year":"2008","unstructured":"Wei, C. et al. Modification of kidney barrier function by the urokinase receptor. Nat. Med. 14, 55\u201363 (2008).","journal-title":"Nat. Med."},{"key":"76050_CR27","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1159\/000490118","volume":"139","author":"MA Saleem","year":"2018","unstructured":"Saleem, M. A. What is the role of soluble urokinase-type plasminogen activator in renal disease?. Nephron 139, 334\u2013341 (2018).","journal-title":"Nephron"},{"key":"76050_CR28","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1053\/j.ajkd.2014.04.030","volume":"64","author":"C Boehlke","year":"2014","unstructured":"Boehlke, C. et al. Hantavirus infection with severe proteinuria and podocyte foot-process effacement. Am. J. Kidney Dis. 64, 452\u2013456 (2014).","journal-title":"Am. J. Kidney Dis."},{"key":"76050_CR29","first-page":"167","volume":"92","author":"Y Collan","year":"1978","unstructured":"Collan, Y., L\u00e4hdevirta, J. & Jokinen, E. J. Electron microscopy of nephropathia epidemica. Renal tubular basement membrane. Am. J. Pathol. 92, 167\u2013172 (1978).","journal-title":"Am. J. Pathol."},{"key":"76050_CR30","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1681\/ASN.2013020173","volume":"24","author":"L Wickman","year":"2013","unstructured":"Wickman, L. et al. Urine podocyte mRNAs, proteinuria, and progression in human glomerular diseases. J. Am. Soc. Nephrol. 24, 2081\u20132095 (2013).","journal-title":"J. Am. Soc. Nephrol."},{"key":"76050_CR31","first-page":"195","volume":"17","author":"PM Andrews","year":"1975","unstructured":"Andrews, P. M. Scanning electron microscopy of the nephrotic kidney. Virchows Archiv. B 17, 195\u2013211 (1975).","journal-title":"Virchows Archiv. B"},{"key":"76050_CR32","first-page":"8","volume":"30","author":"ML Chiang","year":"1988","unstructured":"Chiang, M. L., Hawkins, E. P., Berry, P. L., Barrish, J. & Hill, L. L. Diagnostic and prognostic significance of glomerular epithelial cell vacuolization and podocyte effacement in children with minimal lesion nephrotic syndrome and focal segmental glomerulosclerosis: an ultrastructural study. Clin. Nephrol. 30, 8\u201314 (1988).","journal-title":"Clin. Nephrol."},{"key":"76050_CR33","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1111\/j.1523-1755.1998.00845.x","volume":"53","author":"J Bari\u00e9ty","year":"1998","unstructured":"Bari\u00e9ty, J. et al. Podocytes undergo phenotypic changes and express macrophagic-associated markers in idiopathic collapsing glomerulopathy. Kidney Int. 53, 918\u2013925 (1998).","journal-title":"Kidney Int."},{"key":"76050_CR34","doi-asserted-by":"publisher","first-page":"e0228337","DOI":"10.1371\/journal.pone.0228337","volume":"15","author":"A Ogawa-Akiyama","year":"2020","unstructured":"Ogawa-Akiyama, A. et al. Podocyte autophagy is associated with foot process effacement and proteinuria in patients with minimal change nephrotic syndrome. PLoS ONE 15, e0228337 (2020).","journal-title":"PLoS ONE"},{"key":"76050_CR35","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.crvi.2011.06.006","volume":"334","author":"P Galle","year":"2011","unstructured":"Galle, P. & Labejof, L. In nephrotic syndromes podocytes synthesize and excrete proteins into the tubular fluid: An electron and ion microscopic study. C. R. Biol 334, 713\u2013719 (2011).","journal-title":"C. R. Biol"},{"key":"76050_CR36","first-page":"674360","volume":"2012","author":"I Gavrilovskaya","year":"2012","unstructured":"Gavrilovskaya, I., Gorbunova, E., Koster, F. & Mackow, E. Elevated VEGF levels in pulmonary edema fluid and PBMCs from patients with acute hantavirus pulmonary syndrome. Adv. Virol. 2012, 674360\u2013674368 (2012).","journal-title":"Adv. Virol."},{"key":"76050_CR37","doi-asserted-by":"publisher","first-page":"11227","DOI":"10.1128\/JVI.01405-10","volume":"84","author":"P Shrivastava-Ranjan","year":"2010","unstructured":"Shrivastava-Ranjan, P., Rollin, P. E. & Spiropoulou, C. F. Andes virus disrupts the endothelial cell barrier by induction of vascular endothelial growth factor and downregulation of VE-cadherin. J. Virol. 84, 11227\u201311234 (2010).","journal-title":"J. Virol."},{"key":"76050_CR38","doi-asserted-by":"publisher","first-page":"5797","DOI":"10.1128\/JVI.02397-07","volume":"82","author":"IN Gavrilovskaya","year":"2008","unstructured":"Gavrilovskaya, I. N., Gorbunova, E. E., Mackow, N. A. & Mackow, E. R. Hantaviruses direct endothelial cell permeability by sensitizing cells to the vascular permeability factor VEGF, while angiopoietin 1 and sphingosine 1-phosphate inhibit hantavirus-directed permeability. J. Virol. 82, 5797\u20135806 (2008).","journal-title":"J. Virol."},{"key":"76050_CR39","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12879-018-3583-x","volume":"18","author":"S H\u00e4gele","year":"2018","unstructured":"H\u00e4gele, S. et al. Motility of human renal cells is disturbed by infection with pathogenic hantaviruses. BMC Infect. Dis. 18, 84 (2018).","journal-title":"BMC Infect. Dis."},{"key":"76050_CR40","doi-asserted-by":"publisher","first-page":"9811","DOI":"10.1128\/JVI.00568-11","volume":"85","author":"E Krautkr\u00e4mer","year":"2011","unstructured":"Krautkr\u00e4mer, E., Grouls, S., Stein, N., Reiser, J. & Zeier, M. Pathogenic old world hantaviruses infect renal glomerular and tubular cells and induce disassembling of cell-to-cell contacts. J. Virol. 85, 9811\u20139823 (2011).","journal-title":"J. Virol."},{"key":"76050_CR41","doi-asserted-by":"publisher","first-page":"13647","DOI":"10.1038\/srep13647","volume":"5","author":"M Alfano","year":"2015","unstructured":"Alfano, M. et al. Full-length soluble urokinase plasminogen activator receptor down-modulates nephrin expression in podocytes. Sci. Rep. 5, 13647 (2015).","journal-title":"Sci. Rep."},{"key":"76050_CR42","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.3390\/ijms18071387","volume":"18","author":"C Nusshag","year":"2017","unstructured":"Nusshag, C., Weigand, M. A., Zeier, M., Morath, C. & Brenner, T. Issues of acute kidney injury staging and management in sepsis and critical illness: a narrative review. Int. J. Mol. Sci. 18, 1387 (2017).","journal-title":"Int. J. Mol. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-76050-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-76050-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-76050-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T22:33:46Z","timestamp":1670366026000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-76050-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,5]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["76050"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-76050-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,5]]},"assertion":[{"value":"29 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Reiser J. is a co-founder and shareholder of Trisaq, a biotechnology company developing therapies for renal diseases. The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19117"}}